Welcome to our dedicated page for Pharma-Bio Serv news (Ticker: PBSV), a resource for investors and traders seeking the latest updates and insights on Pharma-Bio Serv stock.
PHARM-BIO SERV INC (PBSV) is a leading player in the life sciences industry, specializing in regulatory compliance, validation, and support services for regulated industries. Established in February 1993, PHARM-BIO SERV offers technical services, product and process transfers, commissioning, process engineering, and technology transfer to a variety of industries including pharmaceutical, medical devices, consumer, chemical, and biotechnology sectors in Puerto Rico, the United States, Brazil, and Europe. The company's integrated service structure is designed to provide comprehensive solutions to meet client needs. PHARM-BIO SERV has diversified its services by introducing new divisions to support clients, such as ScienzaLabs, a laboratory testing facility in Puerto Rico and Spain providing microbiological and analytical testing services; Metrologix, offering calibration program management solutions; and Integratek, providing IT services.
Pharma-Bio Serv (OTCQB:PBSV) reported financial results for the fiscal year ended October 31, 2024. The company experienced a significant decline in performance, with revenues dropping to $9.5 million, representing a decrease of $7.5 million compared to the previous year. The company reported a net loss of $0.8 million, contrasting with a net income of $1.3 million in the prior year.
Despite challenging market conditions, particularly in new investments and projects, the company implemented strategic measures focusing on higher-value services and business development, including technology adoption. The Board of Directors approved a Special Dividend of $0.075 per share, payable around March 20, 2025, demonstrating confidence in their business plan and commitment to shareholder value.
Pharma-Bio Serv (OTCQB:PBSV), a consulting firm serving pharmaceutical, biotechnology, medical device, cosmetic, food and allied products industries, has announced a special dividend of $0.075 per share. The company, which specializes in regulatory affairs, quality, compliance, project management and technology transfer support, will distribute the dividend on March 20, 2025 to shareholders of record as of February 28, 2025.
Pharma-Bio Serv (OTCQB:PBSV), a consulting firm for pharmaceutical and related industries, reported financial results for Q3 2024. The company experienced a significant decline in revenues and profitability. Revenues for the three and nine months ended July 31, 2024, were $2.4 million and $7.2 million respectively, representing decreases of $2.2 million and $6.2 million compared to the same periods last year. The company reported net losses of $0.3 million and $0.8 million for the three and nine-month periods, contrasting with net incomes of $0.5 million and $1.4 million in the previous year. CEO Mr. Sanchez acknowledged industry challenges but highlighted investments in technological tools to identify global business opportunities, aiming to restore profitability and revenue growth.
Pharma-Bio Serv (OTCQB:PBSV), a consulting firm serving various industries including pharmaceuticals, announced a revenue decline for the three and six months ending April 30, 2024. Revenues were $2.4 million and $4.8 million, respectively, marking a decrease of $2.2 million and $4.0 million compared to the same periods last year. The company reported a net loss of $0.2 million and $0.5 million for these periods, compared to net income of $0.4 million and $0.8 million in the previous year. Despite these setbacks, the company is investing in new client relationships and global events to foster growth and stability in the future.
Pharma-Bio Serv, Inc. (OTCQB:PBSV) reported revenue of approximately $4.2 million for the quarter ending January 31, 2023, marking a decrease of $0.8 million year-over-year. However, net income rose to $0.4 million, an increase of $0.1 million compared to the previous year. The CEO, Mr. Sanchez, emphasized the strategic focus on more profitable markets, resulting in improved gross profit percentages. The company operates in markets including Puerto Rico, the US, Europe, and Latin America, providing regulatory compliance consulting services across various industries.
FAQ
What is the current stock price of Pharma-Bio Serv (PBSV)?
What is the market cap of Pharma-Bio Serv (PBSV)?
When was PHARM-BIO SERV INC founded?
What services does PHARM-BIO SERV INC offer?
In which locations does PHARM-BIO SERV INC operate?
What are the divisions created by PHARM-BIO SERV INC to support clients?
What industries does PHARM-BIO SERV INC cater to?
What is the core business of PHARM-BIO SERV INC?
What is the mission of PHARM-BIO SERV INC?
